Latest Strategy Changes News

Renascor Resources has secured an option agreement for land near its Siviour graphite deposit, finalising a critical step in supporting its upstream mining and processing operations. This move advances the company’s Battery Anode Material project readiness with accommodation planned for construction and operational staff.

Echo IQ has secured a pivotal reseller agreement with US-based SARC MedIQ, unlocking access to over 300 healthcare facilities and accelerating adoption of its AI-driven EchoSolv AS technology across the American cardiology landscape.

First Au Limited has launched its inaugural diamond drilling program at the Nimba Gold Project in Liberia, securing ownership of a drilling rig to bolster its West African exploration ambitions.

Yowie Group has appointed Jesse Hamilton as its new Company Secretary, following the resignation of John Patton. The company also confirmed the automatic termination of executive roles held by former directors Nicholas Bolton and John Patton.

Whitefield Income Limited reported a steady net tangible asset backing of $1.26 per share for June 2025, alongside a robust fully franked dividend yield of 7.4%, maintaining its appeal to income-focused investors.

Manuka Resources has boosted the net present value of its Cobar Basin silver and gold project to A$153 million, driven by higher commodity prices, while advancing financing talks and exploring a Mt Boppy open pit cut-back to enhance production.

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Aguia Resources has locked in $2.687 million in loan commitments, including a $500,000 stake from its Executive Chairman, to fund ongoing mine development and exploration in Colombia. The loans feature convertible terms and options issuance, pending shareholder and ASX approvals.

Victory Metals has significantly enhanced its North Stanmore resource with Gallium inclusion and secured major financing commitments exceeding US$200 million, positioning itself as a strategic supplier amid global rare earths tensions.

Neurizon Therapeutics has received positive feedback from the FDA on its plan to resolve the clinical hold on its ALS drug candidate NUZ-001, with key preclinical studies completed ahead of schedule. The company aims to resume clinical trials in late 2025.

Australian Rare Earths Limited (ASX, AR3) has acquired exploration license EL6895, adding 972 km² to its Overland Uranium Project and uncovering significant near-surface uranium potential from historic data. Drilling is set to resume in July 2025 to test this promising new target alongside existing deeper uranium prospects.

Spectur Ltd reports a stronger cash position driven by operational improvements and strategic cloud investments, while FY25 revenue slightly misses guidance due to delayed orders.